Cargando…
Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study
Diabetes generates a great impact on society, as well as a concern for health professionals due to its high and increasing prevalence; there are several studies that demonstrate the effectiveness of vibration platforms and their benefits at a physiological level. The aim of this study will be to ana...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607437/ https://www.ncbi.nlm.nih.gov/pubmed/37892656 http://dx.doi.org/10.3390/jcm12206518 |
_version_ | 1785127541339586560 |
---|---|
author | Fabregat-Fernández, Juan Rodríguez-Pérez, Vicente Llamas-Ramos, Rocío López-Rodríguez, Ana Felicitas Seco-Calvo, Jesús Llamas-Ramos, Inés |
author_facet | Fabregat-Fernández, Juan Rodríguez-Pérez, Vicente Llamas-Ramos, Rocío López-Rodríguez, Ana Felicitas Seco-Calvo, Jesús Llamas-Ramos, Inés |
author_sort | Fabregat-Fernández, Juan |
collection | PubMed |
description | Diabetes generates a great impact on society, as well as a concern for health professionals due to its high and increasing prevalence; there are several studies that demonstrate the effectiveness of vibration platforms and their benefits at a physiological level. The aim of this study will be to analyze the decrease in glycosylated hemoglobin and glycemia levels after the use of whole-body vibration platforms and the possible inclusion of this therapeutic option within the usual treatments. This is a double-blind, randomized controlled trial with parallel group design in a 1:1 ratio. The sample will be composed of people diagnosed with type 2 diabetes mellitus in in the Plasencia area (Cáceres, Extremadura). Participants will be randomly assigned to the intervention or control group using a randomization list and will follow the inclusion criteria: type 2 diabetics between 50 and 60 years of age and not taking diabetes medication. All participants will undergo a determination of glycosylated hemoglobin, blood pressure, lipid profile, weight and height, and different functional tests such as Time Up and Go, 10 Meters Walk Test, and 5 Sit To Stand. The experimental group will perform a whole-body vibration intervention on an oscillating platform for 12 weeks with a weekly frequency of three nonconsecutive days and a duration of 12 min. The exercises will consist of 60 s of work and 60 s with rest. The control group will carry out their normal life insisting on the importance of glycemic controls before and after their daily physical exercise. This study has been registered at clinical.trial.org, ID: NCT 05968222. Whole-body vibration platforms have demonstrated their effectiveness in different pathologies such as stroke, fibromyalgia, sclerosis multiple, or Parkinson’s. For that reason, an improvement in glycemic and lipid values and body composition are expected in people with diabetes after a whole-body vibration intervention for 12 weeks’ duration. In addition, whole-body vibration platforms could be postulated as an alternative to usual treatments. |
format | Online Article Text |
id | pubmed-10607437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106074372023-10-28 Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study Fabregat-Fernández, Juan Rodríguez-Pérez, Vicente Llamas-Ramos, Rocío López-Rodríguez, Ana Felicitas Seco-Calvo, Jesús Llamas-Ramos, Inés J Clin Med Protocol Diabetes generates a great impact on society, as well as a concern for health professionals due to its high and increasing prevalence; there are several studies that demonstrate the effectiveness of vibration platforms and their benefits at a physiological level. The aim of this study will be to analyze the decrease in glycosylated hemoglobin and glycemia levels after the use of whole-body vibration platforms and the possible inclusion of this therapeutic option within the usual treatments. This is a double-blind, randomized controlled trial with parallel group design in a 1:1 ratio. The sample will be composed of people diagnosed with type 2 diabetes mellitus in in the Plasencia area (Cáceres, Extremadura). Participants will be randomly assigned to the intervention or control group using a randomization list and will follow the inclusion criteria: type 2 diabetics between 50 and 60 years of age and not taking diabetes medication. All participants will undergo a determination of glycosylated hemoglobin, blood pressure, lipid profile, weight and height, and different functional tests such as Time Up and Go, 10 Meters Walk Test, and 5 Sit To Stand. The experimental group will perform a whole-body vibration intervention on an oscillating platform for 12 weeks with a weekly frequency of three nonconsecutive days and a duration of 12 min. The exercises will consist of 60 s of work and 60 s with rest. The control group will carry out their normal life insisting on the importance of glycemic controls before and after their daily physical exercise. This study has been registered at clinical.trial.org, ID: NCT 05968222. Whole-body vibration platforms have demonstrated their effectiveness in different pathologies such as stroke, fibromyalgia, sclerosis multiple, or Parkinson’s. For that reason, an improvement in glycemic and lipid values and body composition are expected in people with diabetes after a whole-body vibration intervention for 12 weeks’ duration. In addition, whole-body vibration platforms could be postulated as an alternative to usual treatments. MDPI 2023-10-14 /pmc/articles/PMC10607437/ /pubmed/37892656 http://dx.doi.org/10.3390/jcm12206518 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Protocol Fabregat-Fernández, Juan Rodríguez-Pérez, Vicente Llamas-Ramos, Rocío López-Rodríguez, Ana Felicitas Seco-Calvo, Jesús Llamas-Ramos, Inés Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study |
title | Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study |
title_full | Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study |
title_fullStr | Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study |
title_full_unstemmed | Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study |
title_short | Therapeutic Exercise Intervention Using Vibration Platforms for Glycemic Control in Type 2 Diabetes: A Pilot Study |
title_sort | therapeutic exercise intervention using vibration platforms for glycemic control in type 2 diabetes: a pilot study |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607437/ https://www.ncbi.nlm.nih.gov/pubmed/37892656 http://dx.doi.org/10.3390/jcm12206518 |
work_keys_str_mv | AT fabregatfernandezjuan therapeuticexerciseinterventionusingvibrationplatformsforglycemiccontrolintype2diabetesapilotstudy AT rodriguezperezvicente therapeuticexerciseinterventionusingvibrationplatformsforglycemiccontrolintype2diabetesapilotstudy AT llamasramosrocio therapeuticexerciseinterventionusingvibrationplatformsforglycemiccontrolintype2diabetesapilotstudy AT lopezrodriguezanafelicitas therapeuticexerciseinterventionusingvibrationplatformsforglycemiccontrolintype2diabetesapilotstudy AT secocalvojesus therapeuticexerciseinterventionusingvibrationplatformsforglycemiccontrolintype2diabetesapilotstudy AT llamasramosines therapeuticexerciseinterventionusingvibrationplatformsforglycemiccontrolintype2diabetesapilotstudy |